SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 25.01-16.0%Nov 6 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter V who wrote (3468)6/23/1998 11:22:00 PM
From: JanyBlueEyes  Read Replies (1) of 5736
 
Maisels did not agree with the market numbers - he thinks it's larger!

From the size of market news release 9/97:

"The company estimates that individual bilirubin blood tests on newborn infants (heelsticks), which are not part of a general panel blood test, total approximately 15,000,000 tests performed annually in the United States...."

From CCSI's response to Assensio's false allegations:

2. CCSI's market size estimates are based on an exaggerated estimate of the number of bilirubin tests performed per year.

Dr. Maisels' response is: "In reviewing market studies submitted in business proposals by international medical companies negotiating with CCSI for the Colormate(TM) TLc-BiliTest(TM) distribution, I have found the estimated number of bilirubin tests in the United States to be over 16,000,000 annually."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext